A Teen's ADHD
when the school day does.
MYDAYIS® is the first and only triple-bead mixed amphetamine salts (MAS) formulation that may help with improved attention, with once-daily dosing.1
Primary Endpoint1: In Study 5, patients aged 13-17 treated with Mydayis experienced significant improvement in attention vs placebo based on LS mean PERMP total scores up to 16 h post-dose, measured from 2 h post-dose.WHY MYDAYIS
for prolonged release
For over 20 years, Takeda has been committed to ADHD research to help meet the needs of adolescent patients. Mydayis is the first ADHD treatment to use triple-bead delivery for extended release of MAS medication through the morning, afternoon, and evening.1
Immediate release in the stomach
Release at pH 5.5
Release at pH 7.0
Beads shown are not actual size or color.
Three types of beads in a single capsule release at different pH levels for prolonged amphetamine delivery.1See how it works
Up to 16 hours
post-dose, measured from 2 hours,
vs placebo in patients aged 13-17 as evaluated by PERMP1
IMPORTANT SAFETY INFORMATION (continued)
- Known hypersensitivity to amphetamines or other ingredients of Mydayis. Angioedema and anaphylactic reactions have been reported with other amphetamines.
Use with monoamine oxidase inhibitors (MAOIs) or within 14 days of last MAOI dose, due to increased risk of hypertensive crisis.
PRIMARY ENDPOINT: Adolescent patients receiving Mydayis 25 mg demonstrated significant improvement in attention compared with placebo on PERMP total score measured from 2 hours and continuing up to 16 hours post-dose.1 The post-dose average score over all testing sessions was 256 for Mydayis and 215 for placebo (P<0.0001).2
PERMP Attention in ADHD was measured using the Permanent Product Measure of Performance (PERMP), which is a skill-adjusted math test. The PERMP score is the sum of the number of math problems attempted plus the number of math problems answered correctly in a 10-minute session. Higher scores indicate better attention.1,2
We’ve made it simple for your teen patients and their caregivers to save on their prescription cost with our long-lasting savings program.
*Eligibility and restrictions apply.
*Until the offer expires. Eligibility and restrictions apply.
- Mydayis [package insert]. Lexington, MA; Takeda US Inc.
- Data on file; SPD465-202; Shire US Inc.